logo
Select company
Select metric
84.49%Cash to Assets Ratio
VS
Market
97
Sector
90
Industry
85
History
100
$ 3.07Close
$ 1.6 - $ 3.99 52-Week Range
Ticker Information

Ticker

NRXS

Company Name

NEURAXIS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NYSEMKT

NEURAXIS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRXS - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 7.09M$ 5.99M84.49%
3/31/2025$ 3.03M$ 2.01M66.19%
12/31/2024$ 4.76M$ 3.7M77.7%
9/30/2024$ 1.14M$ 260.88K22.82%
6/30/2024$ 2.63M$ 1.77M67.04%
3/31/2024$ 945.73K$ 81.75K8.64%
12/31/2023$ 509.5K$ 78.56K15.42%
9/30/2023$ 1.24M$ 761.25K61.59%
6/30/2023$ 1.54M$ 51.44K3.34%
3/31/2023$ 1.58M$ 45.46K2.88%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEURAXIS INC's latest trailing twelve months (TTM) Cash to Assets stands at 42.19%.
  • Over the past 5 years, NEURAXIS INC's average Cash to Assets has been 36.16%.
  • The median Cash to Assets for NEURAXIS INC during this period was 22.82%
  • NEURAXIS INC reached its highest Cash to Assets over the past 5 years at 84.49%.
  • The lowest Cash to Assets recorded by NEURAXIS INC in the same timeframe 0.59%

NEURAXIS INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
CAMP : CAMP4 THERAPEUTICS CORP 79.33%DYAI : DYADIC INTERNATIONAL INC 48.84%LPCN : LIPOCINE INC 32.53%TRAW : TRAWS PHARMA INC 83.73%LSTA : LISATA THERAPEUTICS INC 66.91%STTK : SHATTUCK LABS INC 78.4%SONN : SONNET BIOTHERAPEUTICS HOLDINGS INC 15.63%LGVN : LONGEVERON INC 61.7%BOLT : BOLT BIOTHERAPEUTICS INC 13.76%CLSD : CLEARSIDE BIOMEDICAL INC 61.15%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for NEURAXIS INC is calculated as follows: CashnEq [ $ 320.86K ] / Assets [ $ 760.48K ]
(=) Cash to Assets [ 42.19% ]

NRXS - Cash to Assets Ratio, Last 5 years

0.59%

Minimum

Sep 30, 2022

84.49%

Maximum

Jun 30, 2025

36.16%

Average

22.82%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.77% with a standard deviation of 9.51%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.93K
min0%
max40.71%
average9.77%
median6.41%
std9.51%